Cardiac Amyloidosis: An Increasingly Recognized Entity
Cardiac Amyloidosis: An Increasingly Recognized Entity is organized by Baptist Health South Florida.
Course opens: 09/01/2022
Course expires: 08/31/2025
Overview:
Most cardiac amyloidosis cases are due to immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR). Amyloid-induced cardiomyopathy has distinct characteristics compared to non-amyloid cardiomyopathies. As a result, specific management strategies are needed. In this online course, Dr. Bush reviews the pathophysiology and subtypes of cardiac amyloidosis and discuss the available and emerging therapies.
Learning Objectives:
• Review the pathophysiology and subtypes of cardiac amyloidosis.
• Establish the clinical clues for when to suspect cardiac amyloidosis.
• Identify the key principles in making the diagnosis of cardiac amyloidosis.
• Evaluate the available and emerging therapies for cardiac amyloidosis.